AMRK
Price
$20.16
Change
+$0.34 (+1.72%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
701.41M
96 days until earnings call
BIIB
Price
$125.84
Change
-$0.46 (-0.36%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
31.34B
60 days until earnings call
Interact to see
Advertisement

AMRK vs BIIB

Header iconAMRK vs BIIB Comparison
Open Charts AMRK vs BIIBBanner chart's image
A-Mark Precious Metals
Price$20.16
Change+$0.34 (+1.72%)
Volume$2.68K
Capitalization701.41M
Biogen
Price$125.84
Change-$0.46 (-0.36%)
Volume$19.56K
Capitalization31.34B
AMRK vs BIIB Comparison Chart
Loading...
AMRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRK vs. BIIB commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRK is a Hold and BIIB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (AMRK: $19.82 vs. BIIB: $126.30)
Brand notoriety: AMRK: Not notable vs. BIIB: Notable
AMRK represents the Investment Banks/Brokers, while BIIB is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMRK: 70% vs. BIIB: 54%
Market capitalization -- AMRK: $701.41M vs. BIIB: $31.34B
AMRK [@Investment Banks/Brokers] is valued at $701.41M. BIIB’s [@Pharmaceuticals: Major] market capitalization is $31.34B. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $928.5B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Investment Banks/Brokers] industry is $12.04B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRK’s FA Score shows that 1 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • AMRK’s FA Score: 1 green, 4 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRK is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRK’s TA Score shows that 4 TA indicator(s) are bullish while BIIB’s TA Score has 4 bullish TA indicator(s).

  • AMRK’s TA Score: 4 bullish, 4 bearish.
  • BIIB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRK and BIIB are a good buy in the short-term.

Price Growth

AMRK (@Investment Banks/Brokers) experienced а -6.42% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +2.10% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -1.85%. For the same industry, the average monthly price growth was +14.18%, and the average quarterly price growth was +96.41%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.69%. For the same industry, the average monthly price growth was +2.39%, and the average quarterly price growth was -0.07%.

Reported Earning Dates

AMRK is expected to report earnings on Aug 28, 2025.

BIIB is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Investment Banks/Brokers (-1.85% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

@Pharmaceuticals: Major (+1.69% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than AMRK($701M). BIIB has higher P/E ratio than AMRK: BIIB (26.95) vs AMRK (6.82). BIIB YTD gains are higher at: -17.408 vs. AMRK (-26.493). BIIB has higher annual earnings (EBITDA): 2.04B vs. AMRK (194M). BIIB has more cash in the bank: 1.05B vs. AMRK (28.5M). AMRK has less debt than BIIB: AMRK (824M) vs BIIB (7.34B). AMRK (10B) and BIIB (9.84B) have equivalent revenues.
AMRKBIIBAMRK / BIIB
Capitalization701M31.3B2%
EBITDA194M2.04B10%
Gain YTD-26.493-17.408152%
P/E Ratio6.8226.9525%
Revenue10B9.84B102%
Total Cash28.5M1.05B3%
Total Debt824M7.34B11%
FUNDAMENTALS RATINGS
AMRK vs BIIB: Fundamental Ratings
AMRK
BIIB
OUTLOOK RATING
1..100
558
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
7071
PRICE GROWTH RATING
1..100
8861
P/E GROWTH RATING
1..100
4196
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRK's Valuation (23) in the Investment Banks Or Brokers industry is somewhat better than the same rating for BIIB (87) in the Biotechnology industry. This means that AMRK’s stock grew somewhat faster than BIIB’s over the last 12 months.

AMRK's Profit vs Risk Rating (58) in the Investment Banks Or Brokers industry is somewhat better than the same rating for BIIB (100) in the Biotechnology industry. This means that AMRK’s stock grew somewhat faster than BIIB’s over the last 12 months.

AMRK's SMR Rating (70) in the Investment Banks Or Brokers industry is in the same range as BIIB (71) in the Biotechnology industry. This means that AMRK’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's Price Growth Rating (61) in the Biotechnology industry is in the same range as AMRK (88) in the Investment Banks Or Brokers industry. This means that BIIB’s stock grew similarly to AMRK’s over the last 12 months.

AMRK's P/E Growth Rating (41) in the Investment Banks Or Brokers industry is somewhat better than the same rating for BIIB (96) in the Biotechnology industry. This means that AMRK’s stock grew somewhat faster than BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRKBIIB
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 4 days ago
53%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
AMRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPO120.63N/A
N/A
XPO
TCBI72.35N/A
N/A
Texas Capital Bancshares
NFGC1.22N/A
N/A
New Found Gold Corp
CYBN7.02N/A
N/A
Cybin Inc
SBFM1.40-0.02
-1.41%
Sunshine Biopharma Inc

AMRK and

Correlation & Price change

A.I.dvisor tells us that AMRK and NMR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRK and NMR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRK
1D Price
Change %
AMRK100%
-2.46%
NMR - AMRK
32%
Poorly correlated
N/A
SNEX - AMRK
31%
Poorly correlated
-1.53%
PIPR - AMRK
30%
Poorly correlated
-0.41%
TREE - AMRK
30%
Poorly correlated
N/A
HLI - AMRK
29%
Poorly correlated
+0.17%
More

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.41%
AMGN - BIIB
52%
Loosely correlated
+0.21%
NVS - BIIB
48%
Loosely correlated
-0.25%
PFE - BIIB
48%
Loosely correlated
N/A
SNY - BIIB
42%
Loosely correlated
N/A
MRK - BIIB
40%
Loosely correlated
N/A
More